Outcome of congestive heart failure, dilated cardiomyopathy, hypertrophic hyperkinetic disease, and ischemic heart disease in dialysis patients
- PMID: 2143353
- DOI: 10.1159/000168084
Outcome of congestive heart failure, dilated cardiomyopathy, hypertrophic hyperkinetic disease, and ischemic heart disease in dialysis patients
Abstract
Congestive heart failure in dialysis patients is associated with dilated cardiomyopathy, hypertrophic hyperkinetic disease and ischemic heart disease. To determine the natural history of these four diseases, 150 dialysis patients were prospectively followed for 3-5 years. The 2-year cumulative survival rate was 33% in those with recurrent or persistent congestive heart failure vs. 80% in dialysis patients without. Survival was significantly worse in patients with an echocardiographic diagnosis of dilated cardiomyopathy compared to patients with normal echo-cardiogram (2-year survival rate 67 vs. 90%). In hypertrophic hyperkinetic disease the 2-year survival rate was 30% after entry into the study, and 43% after first admission with congestive heart failure. Symptomatic ischemic heart disease did not have an adverse impact on mortality when compared to those without ischemic heart disease. We conclude that congestive heart failure in dialysis patients has a bad prognosis. Its associated disorders include dilated cardiomyopathy and hypertrophic hyperkinetic disease, the latter being associated with a high mortality. As the prognosis for patients with overt ischemic heart disease was not different from patients without, it is likely that the underlying cardiomyopathy directly influenced survival.
Similar articles
-
Congestive heart failure in dialysis patients.Arch Intern Med. 1988 Jul;148(7):1519-25. Arch Intern Med. 1988. PMID: 3382298
-
The natural history of myocardial disease in dialysis patients.J Am Soc Nephrol. 1991 Jul;2(1):2-12. doi: 10.1681/ASN.V212. J Am Soc Nephrol. 1991. PMID: 1832984 Review.
-
Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy.Am J Cardiol. 1987 Mar 1;59(6):634-8. doi: 10.1016/0002-9149(87)91183-0. Am J Cardiol. 1987. PMID: 3825904
-
Cardiovascular factors influencing survival in dialysis patients.Adv Perit Dial. 1996;12:110-9. Adv Perit Dial. 1996. PMID: 8865884 Review.
-
The clinical course of left ventricular hypertrophy in dialysis patients.Nephron. 1990;55(2):114-20. doi: 10.1159/000185937. Nephron. 1990. PMID: 2141918
Cited by
-
High Inferior Vena Cava Diameter with High Left Ventricular End Systolic Diameter as a Risk Factor for Major Adverse Cardiovascular Events, Cardiovascular and Overall Mortality among Chronic Hemodialysis Patients.J Clin Med. 2022 Sep 19;11(18):5485. doi: 10.3390/jcm11185485. J Clin Med. 2022. PMID: 36143131 Free PMC article.
-
Diagnosis and Management of Heart Failure in Long-Term Dialysis Patients.Curr Heart Fail Rep. 2017 Oct;14(5):404-409. doi: 10.1007/s11897-017-0354-8. Curr Heart Fail Rep. 2017. PMID: 28779281 Review.
-
Association of left ventricular hypertrophy with high-sensitive C-reactive protein in hemodialysis patients.Int Urol Nephrol. 2013 Dec;45(6):1679-86. doi: 10.1007/s11255-012-0375-x. Epub 2013 Jan 11. Int Urol Nephrol. 2013. PMID: 23306861
-
Prevalence and prognostic impact of abnormal left ventricular ejection fraction in Hemodialysis patients with end-stage renal disease.BMC Nephrol. 2025 Jul 12;26(1):384. doi: 10.1186/s12882-025-04316-8. BMC Nephrol. 2025. PMID: 40652173 Free PMC article.
-
Coronary Artery Bypass Surgery in End-Stage Renal Disease Patients.Ann Vasc Dis. 2017 Jun 25;10(2):79-87. doi: 10.3400/avd.ra.17-00024. Ann Vasc Dis. 2017. PMID: 29034031 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials